Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

86 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Potential chemotherapeutic targets in the purine metabolism of parasites.
el Kouni MH. el Kouni MH. Pharmacol Ther. 2003 Sep;99(3):283-309. doi: 10.1016/s0163-7258(03)00071-8. Pharmacol Ther. 2003. PMID: 12951162 Review.
Potent combination therapy for human breast tumors with high doses of 5-fluorouracil: remission and lack of host toxicity.
Al Safarjalani ON, Rais R, Naguib FN, el Kouni MH. Al Safarjalani ON, et al. Among authors: el kouni mh. Cancer Chemother Pharmacol. 2012 Jun;69(6):1449-55. doi: 10.1007/s00280-012-1842-x. Epub 2012 Feb 29. Cancer Chemother Pharmacol. 2012. PMID: 22373605
Carbocyclic 6-benzylthioinosine analogues as subversive substrates of Toxoplasma gondii adenosine kinase: biological activities and selective toxicities.
Al Safarjalani ON, Rais RH, Kim YA, Chu CK, Naguib FN, El Kouni MH. Al Safarjalani ON, et al. Among authors: el kouni mh. Biochem Pharmacol. 2010 Oct 1;80(7):955-63. doi: 10.1016/j.bcp.2010.06.001. Epub 2010 Jun 10. Biochem Pharmacol. 2010. PMID: 20541538 Free PMC article.
7-Deaza-6-benzylthioinosine analogues as subversive substrate of Toxoplasma gondii adenosine kinase: activities and selective toxicities.
Al Safarjalani ON, Rais RH, Kim YA, Chu CK, Naguib FN, el Kouni MH. Al Safarjalani ON, et al. Among authors: el kouni mh. Biochem Pharmacol. 2008 Oct 15;76(8):958-66. doi: 10.1016/j.bcp.2008.07.035. Epub 2008 Aug 7. Biochem Pharmacol. 2008. PMID: 18755159 Free PMC article.
Suppression of thymidine phosphorylase expression by promoter methylation in human cancer cells lacking enzyme activity.
Guarcello V, Blanquicett C, Naguib FN, El Kouni MH. Guarcello V, et al. Among authors: el kouni mh. Cancer Chemother Pharmacol. 2008 Jun;62(1):85-96. doi: 10.1007/s00280-007-0578-5. Epub 2007 Sep 1. Cancer Chemother Pharmacol. 2008. PMID: 17805539
Adenosine metabolism in Toxoplasma gondii: potential targets for chemotherapy.
el Kouni MH. el Kouni MH. Curr Pharm Des. 2007;13(6):581-97. doi: 10.2174/138161207780162836. Curr Pharm Des. 2007. PMID: 17346176 Review.
Modulation of 5-fluorouracil host-toxicity and chemotherapeutic efficacy against human colon tumors by 5-(Phenylthio)acyclouridine, a uridine phosphorylase inhibitor.
Al Safarjalani ON, Rais R, Shi J, Schinazi RF, Naguib FN, el Kouni MH. Al Safarjalani ON, et al. Among authors: el kouni mh. Cancer Chemother Pharmacol. 2006 Nov;58(5):692-8. doi: 10.1007/s00280-006-0213-x. Epub 2006 Mar 10. Cancer Chemother Pharmacol. 2006. PMID: 16528530
5-(Phenylthio)acyclouridine: a powerful enhancer of oral uridine bioavailability: relevance to chemotherapy with 5-fluorouracil and other uridine rescue regimens.
Al Safarjalani ON, Zhou XJ, Rais RH, Shi J, Schinazi RF, Naguib FN, El Kouni MH. Al Safarjalani ON, et al. Among authors: el kouni mh. Cancer Chemother Pharmacol. 2005 Jun;55(6):541-51. doi: 10.1007/s00280-004-0967-y. Epub 2005 Feb 24. Cancer Chemother Pharmacol. 2005. PMID: 15729584
Uptake of nitrobenzylthioinosine and purine beta-L-nucleosides by intracellular Toxoplasma gondii.
Al Safarjalani ON, Naguib FN, El Kouni MH. Al Safarjalani ON, et al. Among authors: el kouni mh. Antimicrob Agents Chemother. 2003 Oct;47(10):3247-51. doi: 10.1128/aac.47.10.3247-3251.2003. Antimicrob Agents Chemother. 2003. PMID: 14506037 Free PMC article.
Trends in the design of nucleoside analogues as anti-HIV drugs.
el Kouni MH. el Kouni MH. Curr Pharm Des. 2002;8(8):581-93. doi: 10.2174/1381612024607171. Curr Pharm Des. 2002. PMID: 11945160 Review.
86 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback